Kemira Oyj achieves a settlement with CDC in the damage claim litigation in Helsinki, Finland

Kemira Oyj
Stock Exchange Release
May 19, 2014 at 8.30 am (CET+1)

Kemira has signed an agreement with CDC Cartel Damage Claims Hydrogen Peroxide SA and CDC Holding SA (together "CDC") to settle a lawsuit in Helsinki, Finland. The settlement concerns claims assigned to CDC based on which CDC claimed compensation for alleged damages relating to the alleged old infringement of competition law in the hydrogen peroxide business during 1994-2000. CDC has agreed to withdraw the damage claims and Kemira has agreed to pay to CDC a compensation of EUR 18.5 million and will compensate CDC for its legal costs.

Kemira is satisfied with the settlement as it removes the uncertainty related to the litigation outcome. The settlement also includes significant limitations of liabilities for Kemira regarding the still pending legal actions filed by CDC entities in the Regional Court of Dortmund, Germany in 2009 and in the municipal court in Amsterdam, Netherlands in 2011. Kemira will continue to defend itself against these claims.



For more information, please contact

Kemira Oyj
Jukka Hakkila, Group General Counsel
+358 40 544 2303

Tero Huovinen, VP, Investor Relations
+358 10 862 1980

Kemira is a global chemicals company serving customers in water-intensive industries. We provide expertise and chemicals that improve our customers' water, energy and raw material efficiency. Our focus is on pulp & paper, oil & gas, mining and water treatment. In 2013, Kemira had annual revenue of EUR 2.2 billion and around 4,500 employees. Kemira shares are listed on the Nasdaq OMX Helsinki Ltd.
www.kemira.com